Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Services
6.1 Stem Cell Banking
6.2 Stem Cell Acquisition and testing
6.3 Cryopreservation
Chapter 7 Market Segmentation by Treatment
7.1 Allogeneic Stem Cell Therapy
7.2 Syngeneic Stem Cell Therapy
7.3 Autologous Stem Cell Therapy
Chapter 8 Market Segmentation by Therapeutic Application
8.1 Orthopaedic Treatments
8.2 Cardiovascular Disorders
8.3 Regenerative Medicine
8.4 Neurological Disorders
8.5 Diabetes
Chapter 9 Market Segmentation by Geography
9.1 Europe
9.1.1 Introduction
9.1.2 Spain
9.1.3 UK
9.1.4 France
9.1.5 Russia
9.1.6 Italy
9.1.7 Others
Chapter 10 Competitive Landscape
10.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
10.2 Market Share Analysis
10.3 Strategies Adopted By Top Companies
Chapter 11 Company Profiles
11.1 Cytori Therapeutics Inc.
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Strategic Initiative
11.2 BioTime Inc.
11.3 NsGene
11.4 Aastrom Bioscience
11.5 Fibrocell Science
11.6 TiGenix
11.7 Takara Holdings Inc.
11.8 Cellerix
11.9 GE Healthcare
11.10 VetCell Biosciences Ltd
11.11 CellGenix
11.12 Stem Cell Technologies
11.13 Thermo Fisher Scientific Pvt. Ltd
11.14 Beckton Dickinson and Company
11.15 Brainstorm Cell Therapeutics
Chapter 12 Market Estimates and Forecasting
12.1 Market Estimates and Forecasting 2018-2024(USD Million)
12.1.1 Market Estimation and Forecasting by Services 2018-2024 (USD Million)
12.1.2 Market Estimates and Forecasting by Treatment 2018-2024 (USD Million)
12.1.3 Market Estimates and Forecasting by Therapeutic 2018-2024 (USD Million)
12.1.4 Market Estimates and Forecasting by Geography 2018-2024 (USD Million)
Chapter 13 Market Insights
13.1 Insights of Industry Experts
13.2 Analyst Opinion (Market Understanding)
13.3 Investment Opportunities
Chapter 14 Appendix
14.1 List of Tables
14.2 List of Figures
